Delay-Adjusted Age-Specific COVID-19 Case Fatality Rates in a High Testing Setting: South Korea, February 2020 to February 2021
Abstract
:1. Introduction
2. Materials and Methods
2.1. Data Sources
2.2. Statistical Analysis
3. Results
3.1. Epidemiological Characteristics of COVID-19 in South Korea
3.2. Evolution of Cases and Deaths According to Age Group
3.3. Crude and Delay-Adjusted Risk of Death
4. Discussion
5. Conclusions
Funding
Institutional Review Board Statement
Data Availability Statement
Conflicts of Interest
References
- WHO COVID-19 Weekly Epidemiological Update. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports (accessed on 6 January 2021).
- Walker, P.G.; Whittaker, C.; Watson, O.J.; Baguelin, M.; Winskill, P.; Hamlet, A.; Djafaara, B.A.; Cucunubá, Z.; Mesa, D.O.; Green, W.; et al. The impact of COVID-19 and strategies for mitigation and suppression in low-and middle-income countries. Science 2020, 369, 413–422. [Google Scholar] [CrossRef]
- Reed, C.; Biggerstaff, M.; Finelli, L.; Koonin, L.M.; Beauvais, D.; Uzicanin, A.; Plummer, A.; Bresee, J.; Redd, S.C.; Jernigan, D.B.; et al. Novel framework for assessing epidemiologic effects of influenza epidemics and pandemics. Emerg. Infect. Dis. 2013, 19, 85. [Google Scholar] [CrossRef]
- The Updates of COVID-19 in Republic of Korea. Available online: http://www.kdca.go.kr/board/board.es?mid=a20501010000&bid=0015 (accessed on 2 March 2021).
- Normile, D. Coronavirus cases have dropped sharply in South Korea. What’s the secret to its success. Science 2020, 17, 1–2. [Google Scholar] [CrossRef]
- Share of Total COVID-19 Tests that Were Positive. Available online: https://ourworldindata.org/grapher/covid-19-positive-rate-bar (accessed on 2 March 2021).
- Wu, Z.; McGoogan, J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72,314 cases from the Chinese center for disease control and prevention. JAMA 2020, 323, 1239–1242. [Google Scholar] [CrossRef]
- Oran, D.P.; Topol, E.J. The proportion of SARS-CoV-2 infections that are asymptomatic: A systematic review. Ann. Intern. Med. 2021. [Google Scholar] [CrossRef]
- Sakurai, A.; Sasaki, T.; Kato, S.; Hayashi, M.; Tsuzuki, S.-i.; Ishihara, T.; Iwata, M.; Morise, Z.; Doi, Y. Natural history of asymptomatic SARS-CoV-2 infection. N. Engl. J. Med. 2020, 383, 885–886. [Google Scholar] [CrossRef] [PubMed]
- Workman, J. The proportion of COVID-19 cases that are asymptomatic in South Korea: Comment on Nishiura et al. Int. J. Infect. Dis. 2020, 96, 398. [Google Scholar] [CrossRef]
- Newall, A.; Leong, R.; Nazareno, A.; Muscatello, D.; Wood, J.; Kim, W. Delay-adjusted age-and sex-specific case fatality rates for COVID-19 in South Korea: Evolution in the estimated risk of mortality throughout the epidemic. Int. J. Infect. Dis. 2020, 101, 306–311. [Google Scholar] [CrossRef]
- Verity, R.; Okell, L.C.; Dorigatti, I.; Winskill, P.; Whittaker, C.; Imai, N.; Cuomo-Dannenburg, G.; Thompson, H.; Walker, P.G.; Fu, H. Estimates of the severity of coronavirus disease 2019: A model-based analysis. Lancet Infect. Dis. 2020, 20, 669–677. [Google Scholar] [CrossRef]
- Richardson, S.; Hirsch, J.S.; Narasimhan, M.; Crawford, J.M.; McGinn, T.; Davidson, K.W.; Barnaby, D.P.; Becker, L.B.; Chelico, J.D.; Cohen, S.L. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020, 323, 2052–2059. [Google Scholar] [CrossRef]
- Onder, G.; Rezza, G.; Brusaferro, S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 2020, 323, 1775–1776. [Google Scholar] [CrossRef] [PubMed]
- Wang, C.; Horby, P.W.; Hayden, F.G.; Gao, G.F. A novel coronavirus outbreak of global health concern. Lancet 2020, 395, 470–473. [Google Scholar] [CrossRef][Green Version]
- Sudharsanan, N.; Didzun, O.; Barnighausen, T.; Geldsetzer, P. The contribution of the age distribution of cases to COVID-19 case fatality across countries: A nine-country demographic study. Ann. Intern. Med. 2020, 173, 714–720. [Google Scholar] [CrossRef] [PubMed]
- Abdollahi, E.; Champredon, D.; Langley, J.M.; Galvani, A.P.; Moghadas, S.M. Temporal estimates of case-fatality rate for COVID-19 outbreaks in Canada and the United States. CMAJ 2020, 192, E666–E670. [Google Scholar] [CrossRef] [PubMed]
- Shim, E.; Mizumoto, K.; Choi, W.; Chowell, G. Estimating the risk of COVID-19 death during the course of the outbreak in Korea, February–May 2020. J. Clin. Med. 2020, 9, 1641. [Google Scholar] [CrossRef] [PubMed]
- Yoshikura, H. Two parameters characterizing 2009 H1N1 swine influenza epidemic in different countries/regions of the world. Jpn. J. Infect. Dis. 2009, 62, 411–412. [Google Scholar] [PubMed]
- Nishiura, H.; Klinkenberg, D.; Roberts, M.; Heesterbeek, J.A. Early epidemiological assessment of the virulence of emerging infectious diseases: A case study of an influenza pandemic. PLoS ONE 2009, 4, e6852. [Google Scholar] [CrossRef][Green Version]
- Chen, Z.; Akazawa, K.; Nakamura, T. Estimating the case fatality rate using a constant cure-death hazard ratio. Lifetime Data Anal. 2009, 15, 316–329. [Google Scholar] [CrossRef]
- Garske, T.; Legrand, J.; Donnelly, C.A.; Ward, H.; Cauchemez, S.; Fraser, C.; Ferguson, N.M.; Ghani, A.C. Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ 2009, 339, b2840. [Google Scholar] [CrossRef]
- Ejima, K.; Omori, R.; Cowling, B.J.; Aihara, K.; Nishiura, H. The time required to estimate the case fatality ratio of influenza using only the tip of an iceberg: Joint estimation of the virulence and the transmission potential. Comput. Math. Methods Med. 2012, 2012, 978901. [Google Scholar] [CrossRef][Green Version]
- Shim, E. Regional variability in COVID-19 case fatality rate in Canada, February–December 2020. Int. J. Environ. Res. Public Health 2021, 18, 1839. [Google Scholar] [CrossRef] [PubMed]
- Kayano, T.; Nishiura, H. A Comparison of Case Fatality Risk of COVID-19 between Singapore and Japan. J. Clin. Med. 2020, 9, 3326. [Google Scholar] [CrossRef] [PubMed]
- Kim, J.Y. Letter to the editor: Case of the index patient who caused tertiary transmission of coronavirus disease 2019 in Korea: The application of Lopinavir/Ritonavir for the treatment of COVID-19 pneumonia monitored by quantitative RT-PCR. J. Korean Med. Sci. 2020, 35, e88. [Google Scholar] [CrossRef]
- Kobayashi, T.; Jung, S.-m.; Linton, N.M.; Kinoshita, R.; Hayashi, K.; Miyama, T.; Anzai, A.; Yang, Y.; Yuan, B.; Akhmetzhanov, A.R.; et al. Communicating the risk of death from novel coronavirus disease (COVID-19). J. Clin. Med. 2020, 9, 580. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Hawryluk, I.; Mellan, T.A.; Hoeltgebaum, H.; Mishra, S.; Schnekenberg, R.P.; Whittaker, C.; Zhu, H.; Gandy, A.; Donnelly, C.A.; Flaxman, S.; et al. Inference of COVID-19 epidemiological distributions from Brazilian hospital data. J. R. Soc. Interface 2020, 17, 20200596. [Google Scholar] [CrossRef]
- Wu, J.T.; Leung, K.; Bushman, M.; Kishore, N.; Niehus, R.; de Salazar, P.M.; Cowling, B.J.; Lipsitch, M.; Leung, G.M. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nat. Med. 2020, 26, 506–510. [Google Scholar] [CrossRef][Green Version]
- Munayco, C.; Chowell, G.; Tariq, A.; Undurraga, E.A.; Mizumoto, K. Risk of death by age and gender from CoVID-19 in Peru, March–May, 2020. Aging 2020, 12, 13869. [Google Scholar] [CrossRef]
- Undurraga, E.A.; Chowell, G.; Mizumoto, K. COVID-19 case fatality risk by age and gender in a high testing setting in f America: Chile, March–August 2020. Infect. Dis. Poverty 2021, 10, 11. [Google Scholar] [CrossRef]
- Mizumoto, K.; Dahal, S.; Chowell, G. Spatial variability in the risk of death from COVID-19 in Italy. Int. J. Tuberc. Lung Dis. 2020, 24, 829–837. [Google Scholar] [CrossRef]
- Gutierrez, E.; Rubli, A.; Tavares, T. Delays in death reports and their implications for tracking the evolution of COVID-19. SSRN Electron. J. 2020. [Google Scholar] [CrossRef]
- Population Ages 65 and above (% of Total Population). Available online: https://data.worldbank.org/indicator/SP.POP.65UP.TO.ZS?name_desc=false&view=chart (accessed on 28 February 2021).
- Liu, J.; Xu, J.; Sun, C.; Wang, J.; Wang, X.; Chen, X.; Gao, S. Age-stratified analysis of SARS-CoV-2 infection and case fatality rate in China, Italy, and South Korea. Eur. Rev. Med. Pharmacol. Sci. 2020, 24, 12575–12578. [Google Scholar]
- Rath, R.S.; Lohiya, A.; Ahamed, F.; Kathiresan, J.; Suliankatchi, R.A. Public health response to COVID-19 in selected countries—Hits and misses. J. Fam. Med. Prim. Care 2020, 9, 5580. [Google Scholar]
- Song, S.-K.; Lee, D.-H.; Nam, J.-H.; Kim, K.-T.; Do, J.-S.; Kang, D.-W.; Kim, S.-G.; Cho, M.-R. IgG seroprevalence of COVID-19 among individuals without a history of the coronavirus disease infection in Daegu, Korea. J. Korean Med. Sci. 2020, 35, e269. [Google Scholar] [CrossRef] [PubMed]
- Hauser, A.; Counotte, M.J.; Margossian, C.C.; Konstantinoudis, G.; Low, N.; Althaus, C.L.; Riou, J. Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe. PLoS Med. 2020, 17, e1003189. [Google Scholar] [CrossRef] [PubMed]
- Jung, S.-m.; Akhmetzhanov, A.R.; Hayashi, K.; Linton, N.M.; Yang, Y.; Yuan, B.; Kobayashi, T.; Kinoshita, R.; Nishiura, H. Real-time estimation of the risk of death from novel coronavirus (COVID-19) infection: Inference using exported cases. J. Clin. Med. 2020, 9, 523. [Google Scholar] [CrossRef][Green Version]
- Pan, A.; Liu, L.; Wang, C.; Guo, H.; Hao, X.; Wang, Q.; Huang, J.; He, N.; Yu, H.; Lin, X. Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan, China. JAMA 2020, 323, 1915–1923. [Google Scholar] [CrossRef][Green Version]
- Korean Society of Infectious Diseases; Korean Society of Pediatric Infectious Diseases; Korean Society of Epidemiology; Korean Society for Antimicrobial Therapy; Korean Society for Healthcare-associated Infection Control and Prevention. Korea Centers for Disease Control and Prevention.s Report on the epidemiological features of coronavirus disease 2019 (COVID-19) outbreak in the Republic of Korea from January 19 to March 2, 2020. J. Korean Med. Sci. 2020, 35, e112. [Google Scholar] [CrossRef]
- Pigoga, J.L.; Joiner, A.P.; Chowa, P.; Luong, J.; Mhlanga, M.; Reynolds, T.A.; Wallis, L.A. Evaluating capacity at three government referral hospital emergency units in the kingdom of Eswatini using the WHO Hospital Emergency Unit Assessment Tool. BMC Emerg. Med. 2020, 20, 33. [Google Scholar] [CrossRef]
Age Group (Years) | Latest Estimate (95% CrI) | Range of Median Estimates | Crude Case Fatality Rate |
---|---|---|---|
0–29 | 0.00% (0.00–0.01%) | 0.00–0.01% | 0.00% |
30–39 | 0.06% (0.06–0.06%) | 0.04–6.17% | 0.05% |
40–49 | 0.11% (0.10–0.11%) | 0.09–27.17% | 0.10% |
50–59 | 0.35% (0.34–0.36%) | 0.29–20.41% | 0.32% |
60–69 | 1.46% (1.44–1.49%) | 1.14–37.35% | 1.32% |
70–79 | 7.09% (7.00–7.21%) | 5.75–29.13% | 6.41% |
80+ | 22.88% (22.48–23.29%) | 16.57–35.95% | 20.61% |
All ages | 1.97% (1.94–2.00%) | 1.49–12.33% | 1.79% |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Shim, E. Delay-Adjusted Age-Specific COVID-19 Case Fatality Rates in a High Testing Setting: South Korea, February 2020 to February 2021. Int. J. Environ. Res. Public Health 2021, 18, 5053. https://doi.org/10.3390/ijerph18105053
Shim E. Delay-Adjusted Age-Specific COVID-19 Case Fatality Rates in a High Testing Setting: South Korea, February 2020 to February 2021. International Journal of Environmental Research and Public Health. 2021; 18(10):5053. https://doi.org/10.3390/ijerph18105053
Chicago/Turabian StyleShim, Eunha. 2021. "Delay-Adjusted Age-Specific COVID-19 Case Fatality Rates in a High Testing Setting: South Korea, February 2020 to February 2021" International Journal of Environmental Research and Public Health 18, no. 10: 5053. https://doi.org/10.3390/ijerph18105053